Although many studies have concluded that multisequence MRI radiomics models can reveal tumor heterogeneity from multiple perspectives, our model showed similar performance to the multisequence model developed in the study by Rabinovici-Cohen et al. for predicting the recurrence of hormone receptor-positive breast cancer [30–32]. This evidence concerns the gene NR4A1 and breast cancer.